What Happens to Alcohol Alternatives Once the Regulators Catch Up?
Alcohol alternatives are no longer a niche. Supermarkets stock them, bars list them, and more people are choosing to drink less. Regulation is catching up more slowly. That matters once a product moves beyond copying the taste of alcohol and starts using new functional ingredients. The US, Great Britain and the EU each take a different approach, with consequences for the companies developing these drinks, the brands selling them and the people buying them. GABA Labs and Sentia sit directly within that changing landscape.
Why Alcohol Alternatives Face Different Rules
A bottle of alcohol-free beer is usually made from familiar ingredients, so it sits comfortably within existing food and drink rules. A drink designed around the brain’s GABA system to support a relaxed, social experience raises a different set of questions. The ingredients themselves may be treated as new, and the wording on the label matters just as much as what goes into the bottle.
Regulators are usually looking at three separate questions about any alcohol alternative:
- Is the ingredient safe at the intended level of use? For anything genuinely new, this is often where most of the time and cost sit.
- Is the label accurate? Terms such as “alcohol-free” and “low alcohol” have legal or guideline definitions that differ from country to country.
- Can the claims be supported? Any claim about how a drink affects you needs evidence behind it. Brands therefore need to be precise about the experience they describe and avoid promising outcomes they cannot support.
Those three questions lead to different processes in different markets. A product sold legally in one country cannot simply be assumed to meet the rules somewhere else. For the science behind functional alcohol alternatives, the GABA Labs science page explains how the GABA receptor works.
How a New Ingredient Gets Cleared in the US, UK and EU
There is no global approval that makes a new drink ingredient market-ready everywhere. The US, Great Britain and the EU each have their own route, and they work quite differently.
United States: GRAS
In the US, many food and drink ingredients rely on GRAS, short for “generally recognised as safe”. Under the Federal Food, Drug and Cosmetic Act, a substance is GRAS when qualified experts generally recognise its intended use as safe. GRAS substances are not treated as food additives, so they are exempt from the FDA’s premarket approval process. The safety case must rest either on scientific evidence of the same quality and quantity required for a food additive, or on common use in food before 1 January 1958, according to a Congressional Research Service overview of the framework.
Notifying the FDA of a GRAS conclusion is voluntary under a rule published in August 2016. If a company does notify, the FDA responds by letter within 180 days and can extend that period by 90 days. A company can also reach its own GRAS conclusion and bring a product to market without notifying the FDA, known as self-affirmed GRAS. Critics argue that this allows industry to regulate itself; others warn that mandatory review could put more strain on FDA resources.
Great Britain: novel food authorisation
In Great Britain, a food is “novel” if it was not used for human consumption to a significant degree in the UK or EU before 15 May 1997. Novel foods generally need authorisation before sale. The Food Standards Agency’s guidance on novel foods sets out four broad steps:
- Check the status. First confirm whether the product is already authorised and whether the intended use is covered. If it is unclear whether something is novel, the business can make a formal consultation request and provide supporting evidence.
- If the product is not authorised, the business submits a dossier through the regulated products authorisation portal.
- The process includes a scientific safety assessment, followed by risk management considerations and public consultation.
- The Food Standards Agency and Food Standards Scotland make independent recommendations to ministers, who take the authorisation decision. Northern Ireland follows the EU process instead.
The FSA also notes that taste trials may be permissible before authorisation where the main purpose is research and development rather than publicity.
European Union: EFSA and the Commission
The EU uses a similar definition, again using 1997 as the cut-off. Since 1 January 2018, the European Commission has been responsible for authorising novel foods and asks the European Food Safety Authority to assess their safety. The EFSA novel food page explains that applicants must provide data on composition, nutrition, toxicology and allergenicity, alongside details of the production process and proposed uses. EFSA has nine months to complete its assessment, although the clock pauses if it asks for more information. The Commission then seeks the views of Member State authorities before deciding whether to approve the food and at what quantities it may be used.
Each regulatory pathway takes time and requires a real evidence package. For a company planning to license an ingredient to other drinks brands, regulatory clearance is a major commercial milestone. GABA Labs says on its drinks companies page that it will license ingredients to the drinks industry as they become ready for launch.
What Is Changing in 2026
Two regulatory developments in 2026 matter in particular.
GRAS reform in the US. In March 2025, the US Health Secretary directed the FDA to explore rulemaking that would remove the self-affirmed GRAS pathway. In December 2025 the FDA sent a proposed GRAS rule to the Office of Management and Budget for review. As of the Congressional Research Service’s July 2026 note, that review was still pending and the text had not been made public. The FDA’s regulatory agenda suggests that the proposal may make GRAS submissions mandatory. If that happens, brands already putting new ingredients through formal review may be better placed than those relying on self-affirmed conclusions. The position is still moving, so the latest guidance needs checking before anyone relies on it.
Labelling thresholds in the UK. In England, the current guidance is that a drink can be called “alcohol-free” at 0.05% ABV or lower, and “low alcohol” at up to 1.2% ABV. These guidelines are non-statutory. The government consulted on raising the alcohol-free limit to 0.5% in September 2023, which would bring England closer to the threshold used in many European countries. According to FoodNavigator’s July 2026 coverage, the government’s 2025 10 Year Health Plan said it would consult on changing the upper strength threshold to 0.5% and explore options to restrict access to no and low alcohol products, including a ban on sales to under 18s. No decision has been reported yet.
An “alcohol-free” label does not mean exactly the same thing in every country. It is worth checking the ABV rather than relying on the descriptor alone, especially when comparing a genuine 0.0% drink with one that sits just below a local threshold.
What This Means for Brands, Retailers and Drinkers
Clearer rules will shape non-alcoholic beverage trends and raise the bar for the whole category. They also affect each part of the market differently.
- Brands: Ingredient clearance can become a commercial advantage. A product with a clear regulatory route is easier to list, insure and scale than one relying on a grey area.
- Retailers and venues: Clear descriptors make it easier to stock, label and serve these drinks responsibly, including handling age checks if the rules on under-18 sales change.
- Drinkers: More consistent labels and closer scrutiny of claims make it easier to understand what is in the glass and what a product can reasonably be expected to do.
For GABA Labs, stricter rules make the distinction between a flavoured alcohol-free drink and a functional alcohol alternative more important. If a product is intended to offer the relaxed, social experience people value in alcohol, without the alcohol, the mechanism and evidence behind it matter. You can see that thinking in GABA Labs’ work for consumers and socialisers and in its published scientific studies.
Where Sentia Fits In
Sentia is a range of GABA-enhancing functional drinks built on technology developed by GABA Labs, and it is already sold in the UK, US and EU. It gives adult social drinkers another option when they want the relaxed, sociable side of drinking without alcohol. You can read more about the range at sentiaspirits.com.
Sentia is useful here because it turns a regulatory discussion into a live consumer example. It is already sold across several markets while the wider rules continue to evolve. Clear regulation matters because customers should be able to understand what a label means in the market where they buy it and trust that claims about the product are backed by evidence.
Frequently Asked Questions
Are alcohol alternatives regulated?
Yes. Alcohol alternatives are regulated as food and drink products. Ingredients must be safe for their intended use and labels must be accurate. New ingredients may need extra clearance, such as GRAS review in the US or novel food authorisation in Great Britain and the EU. Each market also sets its own rules for terms such as “alcohol-free”.
What does GRAS mean for a drink ingredient?
GRAS stands for “generally recognised as safe”. It means qualified experts generally agree an ingredient is safe for its intended use, so it does not need the FDA’s formal food additive approval. Companies can notify the FDA voluntarily and receive a written response, or reach the conclusion themselves. Proposed US reforms may change that.
What does alcohol-free mean on a UK label?
In England, current non-statutory guidance says a drink can be described as “alcohol-free” at no more than 0.05% ABV and “low alcohol” at up to 1.2% ABV. The government has consulted on raising the alcohol-free limit to 0.5%, closer to the threshold used across much of Europe, but no decision has been reported.
Does a new drink ingredient need novel food approval in the UK and EU?
Usually, yes. If an ingredient was not widely eaten or drunk in the UK or EU before 15 May 1997, it is generally treated as a novel food and needs authorisation before sale. In Great Britain, the FSA and FSS assess it and ministers decide. In the EU, EFSA assesses it and the Commission decides with Member States.
Is Sentia available in the UK, US and EU?
Yes. Sentia is a GABA-enhancing functional drink developed using GABA Labs technology and sold in the UK, US and EU. It contains no alcohol and is designed for adult social drinkers looking for the relaxed, social side of a drink without ethanol. You can find out more at sentiaspirits.com.
About Author
Senior Full Stack Developer and Team Lead at Gaba Labs with over 9 years of experience building high-performance web and mobile solutions.
